London · Delayed Price · Currency is GBP · Price in GBX CRISM Therapeutics Statistics
Total Valuation
AIM:CRTX has a market cap or net worth of GBP 5.83 million. The enterprise value is 4.70 million.
| Market Cap | 5.83M |
| Enterprise Value | 4.70M |
Important Dates
The next estimated earnings date is Thursday, September 17, 2026.
| Earnings Date | Sep 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AIM:CRTX has 54.24 million shares outstanding. The number of shares has increased by 14.30% in one year.
| Current Share Class | 54.24M |
| Shares Outstanding | 54.24M |
| Shares Change (YoY) | +14.30% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 38.46% |
| Owned by Institutions (%) | 17.52% |
| Float | 31.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 25.24 |
| PB Ratio | 4.12 |
| P/TBV Ratio | 4.44 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 20.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.35
| Current Ratio | 4.35 |
| Quick Ratio | 4.35 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -129.78% and return on invested capital (ROIC) is -81.20%.
| Return on Equity (ROE) | -129.78% |
| Return on Assets (ROA) | -64.97% |
| Return on Invested Capital (ROIC) | -81.20% |
| Return on Capital Employed (ROCE) | -132.63% |
| Weighted Average Cost of Capital (WACC) | 7.55% |
| Revenue Per Employee | 57,750 |
| Profits Per Employee | -475,750 |
| Employee Count | 4 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +4.55% in the last 52 weeks. The beta is 0.60, so AIM:CRTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.60 |
| 52-Week Price Change | +4.55% |
| 50-Day Moving Average | 11.22 |
| 200-Day Moving Average | 11.46 |
| Relative Strength Index (RSI) | 65.19 |
| Average Volume (20 Days) | 205,595 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM:CRTX had revenue of GBP 231,000 and -1.90 million in losses. Loss per share was -0.05.
| Revenue | 231,000 |
| Gross Profit | 131,000 |
| Operating Income | -1.88M |
| Pretax Income | -1.88M |
| Net Income | -1.90M |
| EBITDA | -1.86M |
| EBIT | -1.88M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 1.13 million in cash and n/a in debt, with a net cash position of 1.13 million or 0.02 per share.
| Cash & Cash Equivalents | 1.13M |
| Total Debt | n/a |
| Net Cash | 1.13M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 1.42M |
| Book Value Per Share | 0.04 |
| Working Capital | 1.28M |
Cash Flow
| Operating Cash Flow | -1.97M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 17,000 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 56.71% |
| Operating Margin | -812.99% |
| Pretax Margin | -812.99% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AIM:CRTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.30% |
| Shareholder Yield | -14.30% |
| Earnings Yield | -32.64% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 31, 2024. It was a reverse split with a ratio of 0.00625.
| Last Split Date | May 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.00625 |
Scores
AIM:CRTX has an Altman Z-Score of 1.33 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.33 |
| Piotroski F-Score | 2 |